PLK1 and small cell lung carcinoma: PLK1 has several experimental inhibitory drugs, so we were able to validate the prediction derived from DrugSniper by exploring the efficacy of two commercially available PLK1 inhibitors, Volasertib and BI2536, over a panel of SCLC cells in a cell viability (MTS) assay.